Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Sarana Meditama Metropolitan Tbk (SAME) Fair Value & Analysis

Healthcare · ID · Market cap 4.9T IDR

Price320.00 IDR
Fair Value42.49 IDR
Upside-86.7%
Quality86/100
Evidence: Medium Range 28.91 IDR – 61.63 IDR

Analysis

PT Sarana Meditama Metropolitan Tbk (SAME) currently trades at 320.00 IDR, while our model-based Fair Value estimate is 42.49 IDR — implying the stock looks roughly 86.7% overvalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -73% Fresenius SE (FSNUY) -27% 5225 (5225) -70% IHHHF (IHHHF) -26% Tenet Healthcare Corporation (THC) +74% Rede D'Or São Luiz S.A (RDOR3) -7%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.